These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7525544)

  • 1. Modification of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and its derivative ND 28 with polyethylene glycol.
    Yamasaki M; Asano M; Okabe M; Morimoto M; Yokoo Y
    J Biochem; 1994 May; 115(5):814-9. PubMed ID: 7525544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on rhG-CSF modified with polyethylene glycol].
    Zhang LL; Zheng CY; Lei JD; Ma GH; Su ZG; Wang L
    Sheng Wu Gong Cheng Xue Bao; 2005 Nov; 21(6):965-9. PubMed ID: 16468354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged circulation of recombinant human granulocyte-colony stimulating factor by covalent linkage to albumin through a heterobifunctional polyethylene glycol.
    Paige AG; Whitcomb KL; Liu J; Kinstler O
    Pharm Res; 1995 Dec; 12(12):1883-8. PubMed ID: 8786961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of recombinant human granulocyte colony-stimulating factor modified by polyethylene glycol on anticancer drug-induced neutropenia in mice.
    Ishikawa M; Okada Y; Satake-Ishikawa R; Kakitani M; Kawagishi M; Matsuki S; Kusaka M; Asano K
    Gen Pharmacol; 1994 May; 25(3):533-7. PubMed ID: 7523237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine-specific PEGylation of rhG-CSF via selenylsulfide bond.
    Kunstelj M; Fidler K; Skrajnar S; Kenig M; Smilović V; Kusterle M; Caserman S; Zore I; Porekar VG; Jevševar S
    Bioconjug Chem; 2013 Jun; 24(6):889-96. PubMed ID: 23600957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
    Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
    Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities.
    Tiwari D; Haque S; Jawed A; Mishra MK; Govender T; Kruger HG
    Protein Pept Lett; 2015; 22(10):877-84. PubMed ID: 26216266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
    Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
    Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of recombinant human granulocyte colony-stimulating factor (rhG-CSF) derivatives: KW-2228 and other derivatives.
    Yamasaki M; Konishi N; Yamaguchi K; Itoh S; Yokoo Y
    Biosci Biotechnol Biochem; 1998 Aug; 62(8):1528-34. PubMed ID: 9757559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Separation and purification of PEGylated rhG-CSF by two-step ion-exchange chromatography].
    Chen T; Yun Q; Bi JX; Ma GH; Su ZG
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):284-8. PubMed ID: 16013491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C; Ji B; Hu X; Yang C; Sun W; Zhao X; Li L; Li X; Zhang L
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of PEG-rhG-CSF and rHSA-hG-CSF in mice determined with ELISA].
    Ma GC; Chen SQ; Zhu ZH; Huang YS; Pan HQ; Zhou JB
    Yao Xue Xue Bao; 2007 Feb; 42(2):197-200. PubMed ID: 17518051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of site-specific polyethylene glycol modification of recombinant human granulocyte colony-stimulating factor on its biologic activities.
    Hao Y; Chen J; Wang X; Zhu H; Rong Z
    BioDrugs; 2006; 20(6):357-62. PubMed ID: 17176123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a Pichia pastoris strain efficiently producing recombinant human granulocyte-colony stimulating factor (rhG-CSF) and study of its biological activity on bone marrow cells.
    Pykhtina MB; Romanov VP; Miroshnichenko SM; Beklemishev AB
    Mol Biol Rep; 2020 Jan; 47(1):607-620. PubMed ID: 31713007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled clinical trial of polyethylene glycol recombinant human granulocyte colony-stimulating factor in the treatment of neutropenia after chemotherapy for breast cancer.
    Huang W; Liu J; Zeng Y; Wu F; Li N; Chen K; Hong Y; Wang L; Zhen H; Lin L
    Cancer Chemother Pharmacol; 2018 Oct; 82(4):607-613. PubMed ID: 30043207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography.
    Yun Q; Yang RE; Chen T; Bi J; Ma G; Su Z
    J Biotechnol; 2005 Jul; 118(1):67-74. PubMed ID: 15904987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo.
    Satake-Ishikawa R; Ishikawa M; Okada Y; Kakitani M; Kawagishi M; Matsuki S; Asano K
    Cell Struct Funct; 1992 Jun; 17(3):157-60. PubMed ID: 1379521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Production and Characterization of Recombinant Human Granulocyte Colony Stimulating Factor from E. coli under Optimized Downstream Processes.
    Vemula S; Thunuguntla R; Dedaniya A; Kokkiligadda S; Palle C; Ronda SR
    Protein Expr Purif; 2015 Apr; 108():62-72. PubMed ID: 25659501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
    Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.